Yan Zhang

Yan Zhang

Auto-generated profile, based on publicly available information

Yan Zhang

Shanxi Provincial Key Laboratory of Rheumatism Immune Microecology, Taiyuan 030000, Shanxi, China; Key Laboratory of Cellular Physiology at Shanxi Medical University, Ministry of Education, Taiyuan 030000, Shanxi, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2024 in Exploration of Medicine
Verified
Journal Article
Open access
PDF file
QSQin-Yi Su
Qin-Yi Su
YZYan Zhang
Yan Zhang
DQDan Qiao
Dan Qiao
XSXia Song
Xia Song
YSYang Shi
Yang Shi
SZsheng xiao zhang
sheng xiao zhang
Background: Rheumatoid arthritis (RA) is an autoimmune joint disease with systemic manifestations. Emerging evidence implicates the gut microbiota in the pathophysiology of RA. However, the specific changes in the gut microbiota in RA patients remain poorly understood. Methods: We conducted a comprehensive search of PubMed, EMBASE, Web of Science, Cochrane Library, MEDLINE, Wanfang, VIP, CBM, and CNKI from the time the databases were created until October, 2023. To evaluate changes in α-diversity and the abundance of certain microbiota families in RA, standardized mean difference (SMD) and 95% confidence interval (CI) calculations were made. Results: Firstly, we evaluated the changes in α-diversity of gut microbes in patients with RA compared to healthy controls. Our analysis of 18 studies revealed a significant decrease in richness and evenness among RA patients. Importantly, the subgroup analysis suggested the decrease in α-diversity was more significant in treatment naïve patients rather than those who received anti-rheumatic medication. Additionally, in the subgroup analysis of 316 patients stratified by baseline disease activity, no significant differences in α-diversity were detected between groups. Discussion: Our analysis further evidence of altered α-diversity and the relative abundance of specific bacteria in RA. These findings contribute to our understanding of the role of gut microbiota dysbiosis in the pathogenesis of RA. Further research is warranted to elucidate the underlying mechanisms and explore the potential therapeutic implications of targeting the gut microbiota in RA management.

27 May 2020 in Nanomedicine
Verified
Journal Article
Closed access
BXBohui Xu
Bohui Xu
YZYan Zhang
Yan Zhang
HYHan Yang
Han Yang
TLTingting Liu
Tingting Liu
YLYoujia Lu
Youjia Lu
TWThomas Webster
Thomas Webster
Aim: This study examined nanoparticle entry into tumor-associated vascular endothelial cells during transport to hepatocellular carcinoma cells and tumors. Materials & methods: siVEGF was loaded in...